Arthritis, Musculoskeletal and Skin Diseases Research in North Carolina
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $118 million to recipients in North Carolina in 135 grants from fiscal 2021 to 2025, 4.5% of the program's national total. Duke University received the most, $59.6 million.
- Awarded in North Carolina$118 million
- Awards135
- Share of the program4.5%
- Rank among states5th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 62 | $19.6 million |
| FY 2022 | 57 | $18.9 million |
| FY 2023 | 59 | $23.7 million |
| FY 2024 | 70 | $26.0 million |
| FY 2025 | 74 | $30.3 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Duke University | Colleges and universities | 60 | $59.6 million |
| University of North Carolina at Chapel Hill | Colleges and universities | 47 | $32.6 million |
| North Carolina State University | Colleges and universities | 10 | $9.8 million |
| Wake Forest University | Colleges and universities | 4 | $7.7 million |
| Wake Forest University Health Sciences | Colleges and universities | 4 | $3.2 million |
| Cytex Therapeutics Inc | Small businesses | 3 | $2.3 million |
| Eydis Bio, Inc. | Small businesses | 1 | $1.7 million |
| East Carolina University | Colleges and universities | 4 | $1.2 million |
| Reselute, Inc. | Small businesses | 1 | $314,362 |
| Bedrock Therapeutics, Inc. | Small businesses | 1 | $1 |
Open opportunities under this program
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 62 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to North Carolina?
$118 million from fiscal 2021 to 2025, across 135 awards. North Carolina ranks 5th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in North Carolina?
The largest recipient is Duke University, with $59.6 million in 60 awards. Next are University of North Carolina at Chapel Hill and North Carolina State University.
Can organizations in North Carolina apply now?
Yes, 62 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States